Brief: Kiromic Biopharma Provides Update On IND Filings On Its Off-The-Shelf, Allogeneic Car-T For Solid Tumors
16/07/2021 19:57
July 16 (Reuters) - Kiromic Biopharma Inc KRBP.O :
* KIROMIC BIOPHARMA PROVIDES UPDATE ON IND FILINGS ON ITS
OFF-THE-SHELF, ALLOGENEIC CAR-T FOR SOLID TUMORS
* KIROMIC BIOPHARMA - TIMELINE FOR COMMENCEMENT OF DOSING OF
FIRST
IN HUMAN CLINICAL TRIAL EXPECTED TO BE TIGHTER, STILL PLAN ON
DELIVERING IN 3Q 2021
Source text for Eikon: ID:nBw6hvKhba
Further company coverage: KRBP.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Kiromic Biopharma
See all newsBrief: Kiromic Biopharma Files For Offering Up To 1 Million Units
Brief: Kiromic Biopharma Applies To List Common Stock On The NYSE American Under Symbol 'KRBP'
Brief: Kiromic Biopharma Advances Deltacel-01 Into Expansion Phase Following Safety Monitoring Committee's Unanimous Recommendation
Brief: Kiromic Biopharma Reports Favorable Results At Six Weeks From Fourth Patient In Deltacel-01 Clinical Trial
Brief: Kiromic BioPharma Adds UPMC as Fourth Deltacel-01 Clinical Trial Site